Eli Lilly Fast-Tracks Retatrutide Data Release, Strengthening Position in Weight Loss MarketRyan LongFebruary 6, 2025February 6, 2025 February 6, 2025February 6, 2025 Eli Lilly (NYSE: LLY) has announced that data from a late-stage trial of its next-generation weight loss drug, retatrutide, is expected to be released later...
